must be BBF on the bid
sure over $ 2 in the next days or weeks
USALEM | Tue Dec 16, 2014 7:19am EST
JERUSALEM, Dec 16 (Reuters) - Swiss drugmaker Novartis AG bought a 12.8 percent stake in Israeli biopharmaceutical company BioLineRX Ltd as part of a multi-year collaboration deal, BioLineRX said on Tuesday.
Under the agreement, Novartis, which invested an initial $10 million, will evaluate projects presented by BioLineRX for development and future licensing, the Israeli firm said in a statement. They hope to develop up to three clinical projects.
Novartis acquired an initial 5 million American depositary shares of BioLineRx in a private transaction at $2.00 a share.
Sentiment: Strong Buy
next leg up starting
after ROTH presentation something is clearly up
Zybrestat is Superior than Roches Avastin Combo drug !!
Really hope BBF shorts more !! Achilion Nuked you and Oxgn soon
Cover now! !
accumulation is ongoing
GENE last weeks and Oxigene inc is next play
Oxigene inc fair Market Cap is over 300 Million Dollar !!
Fund's buying again and again !